{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:59:01Z","timestamp":1773763141272,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/ico.0b013e3182775f8d","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T09:43:59Z","timestamp":1360748639000},"page":"992-997","source":"Crossref","is-referenced-by-count":82,"title":["Topical Ranibizumab as a Treatment of Corneal Neovascularization"],"prefix":"10.1097","volume":"32","author":[{"given":"Giulio","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Dastjerdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Okanobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Fu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Amparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nambi","family":"Nallasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":". Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-20-20210204","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R3-20-20210204","first-page":"2485","article-title":"Loss and restoration of immune privilege in eyes with corneal neovascularization.","volume":"37","author":"Dana","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-20-20210204","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":". Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group.","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"key":"R5-20-20210204","first-page":"111","article-title":"Origin of corticosteroid glaucoma.","volume":"304","author":"Bremer","year":"2007","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"R6-20-20210204","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels.","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20-20210204","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00003226-199109000-00012","article-title":"Photodynamic therapy for corneal neovascularization.","volume":"10","author":"Epstein","year":"1991","journal-title":"Cornea"},{"key":"R8-20-20210204","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajo.2005.11.003","article-title":". Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphrin ether.","volume":"141","author":"Sheppard","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R9-20-20210204","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjo.2003.035071","article-title":". Photodynamic therapy for corneal neovascularisation and lipid degeneration.","volume":"88","author":"Brooks","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R10-20-20210204","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00006324-199302000-00010","article-title":"Role of lasers in eye care.","volume":"70","author":"Lyle","year":"1993","journal-title":"Optom Vis Sci"},{"key":"R11-20-20210204","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/ICO.0b013e3181b53310","article-title":"Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.","volume":"29","author":"Yoon","year":"2010","journal-title":"Cornea"},{"key":"R12-20-20210204","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20-20210204","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":". Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-20-20210204","first-page":"448","article-title":"Dursun F, et al..","volume":"5","author":"Dursun","year":"2012","journal-title":"Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model Int J Ophthalmol"},{"key":"R18-20-20210204","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/13543780902855316","article-title":"VEGF inhibitors for the treatment of neovascular age-related macular degeneration.","volume":"18","author":"Barakat","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R19-20-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":". Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R20-20-20210204","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/eye.2008.88","article-title":"Anti-VEGF therapy: comparison of current and future agents.","volume":"22","author":"Pieramici","year":"2008","journal-title":"Eye"},{"key":"R21-20-20210204","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":". Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"R22-20-20210204","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":". The effect of topical bevacizumab on corneal neovascularization.","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"R23-20-20210204","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1755-3768.2009.01585.x","article-title":"Subconjunctival bevacizumab for corneal neovascularization.","volume":"88","author":"Zaki","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R24-20-20210204","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":". Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization.","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-20-20210204","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":". Bevacizumab application delays epithelial healing in rabbit cornea.","volume":"50","author":"Kim","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20-20210204","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1167\/iovs.07-1418","article-title":". Vascular endothelial growth factor mediates corneal nerve repair.","volume":"49","author":"Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-20-20210204","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/ICO.0b013e3181d927b9","article-title":". The effect of subconjunctival ranibizumab on primary pterygium: a pilot study.","volume":"29","author":"Mandalos","year":"2010","journal-title":"Cornea"},{"key":"R28-20-20210204","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bjo.2008.155291","article-title":"Treatment of inflamed pterygia or residual pterygial bed.","volume":"93","author":"Mansour","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R29-20-20210204","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IOP.0b013e3182392f29","article-title":"Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study.","volume":"28","author":"Finger","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R30-20-20210204","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bjo.2008.156489","article-title":"Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension.","volume":"93","author":"Teng","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R31-20-20210204","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/14740330903418422","article-title":"Clinical safety of ranibizumab in age-related macular degeneration.","volume":"9","author":"Schmidt-Erfurth","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"R33-20-20210204","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1167\/iovs.11-7871","article-title":". Corneal penetration of topical and subconjunctival bevacizumab.","volume":"52","author":"Dastjerdi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3182775f8d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:34:37Z","timestamp":1621884877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201307000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3182775f8d","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}